sr 46349b has been researched along with ipsapirone in 1 studies
Studies (sr 46349b) | Trials (sr 46349b) | Recent Studies (post-2010) (sr 46349b) | Studies (ipsapirone) | Trials (ipsapirone) | Recent Studies (post-2010) (ipsapirone) |
---|---|---|---|---|---|
51 | 1 | 7 | 373 | 58 | 14 |
Protein | Taxonomy | sr 46349b (IC50) | ipsapirone (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 2C | Rattus norvegicus (Norway rat) | 10 | |
Alpha-2A adrenergic receptor | Homo sapiens (human) | 1 | |
5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 10 | |
Alpha-2B adrenergic receptor | Homo sapiens (human) | 1 | |
Alpha-2C adrenergic receptor | Homo sapiens (human) | 1 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.0082 | |
D(4) dopamine receptor | Homo sapiens (human) | 1.8 | |
Alpha-1D adrenergic receptor | Homo sapiens (human) | 0.5 | |
5-hydroxytryptamine receptor 2B | Rattus norvegicus (Norway rat) | 10 | |
Alpha-1A adrenergic receptor | Homo sapiens (human) | 0.5 | |
Alpha-1B adrenergic receptor | Homo sapiens (human) | 0.5 | |
D(3) dopamine receptor | Homo sapiens (human) | 1.2 | |
D(2) dopamine receptor | Rattus norvegicus (Norway rat) | 2.9 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Cruz, AP; Morato, S; Motta, VA; Pinheiro, AP; Setem, J | 1 |
1 other study(ies) available for sr 46349b and ipsapirone
Article | Year |
---|---|
Ethopharmacological analysis of 5-HT ligands on the rat elevated plus-maze.
Topics: Animals; Anxiety; Behavior, Animal; Bridged Bicyclo Compounds, Heterocyclic; Cyclic S-Oxides; Exploratory Behavior; Fluorobenzenes; Indoles; Male; Naphthalenes; Phenols; Piperazines; Pyrimidines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Receptors, Serotonin, 5-HT3; Risk Assessment; Serotonin Agents; Serotonin Antagonists; Serotonin Receptor Agonists | 1999 |